Cerebral Palsy clinical trials

Explore recruiting cerebral palsy clinical trials.

Recruiting cerebral palsy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cerebral Palsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Intrathecal baclofen pump versus selective dorsal rhizotomy for non-ambulatory children with cerebral palsy

Netherlands, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

TOXSIALO-TRIAL : Evaluation of the long-term efficacy of the injection of botulinum toxin A into the salivary glands versus scopolamine patches in the treatment of drooling in children over 4 years old with cerebral palsy.

France

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, Double-Blinded, Vehicle-Controlled, Crossover Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intranasal Cenegermin (Recombinant Human Nerve Growth Factor [rhNGF]) in Pediatric Participants with Spastic Cerebral Palsy (CP).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

Portugal, Belgium, Spain, Italy, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

iSTOP-CP: intranasal Stem Cells to treat Perinatal brain injury to combat Cerebral Palsy

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised controlled trial in preterm infants comparing prophylactic with selective “Less Invasive Surfactant Administration” (pro.LISA)

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cerebral Palsy trials by city

Cerebral Palsy in Toronto Cerebral Palsy in Vancouver Cerebral Palsy in Montreal Cerebral Palsy in Calgary Cerebral Palsy in Edmonton Cerebral Palsy in Ottawa Cerebral Palsy in Winnipeg Cerebral Palsy in Quebec City Cerebral Palsy in Hamilton Cerebral Palsy in Kitchener Cerebral Palsy in London Cerebral Palsy in Halifax Cerebral Palsy in New York Cerebral Palsy in Los Angeles Cerebral Palsy in Chicago Cerebral Palsy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease